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metabolite of clopidogrel and its antiplatelet effects. Meanwhile, ABCB1 C3435T also
plays an important role in intestinal absorption of clopidogrel, which will further affect
the exposure to clopi-H4.
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Objectives: Obesity is associated with an increased cardiovascular events in the
general population. However, recent studies have shown a paradoxic relation between
obesity and adverse outcomes in patients with type 2 diabetes, coronary artery disease,
heart failure, or hypertension. However, whether this phenomenon exists in patients
with acute coronary syndrome (ACS) but without diabetes is not known. The aim of
the study was to assess the impact of obesity on adverse outcomes in patients with
acute coronary syndrome (ACS) but without diabetes.
Methods: A total of 571 patients with ACS but without diabetes (72.5% was men,
mean age was 59.9  11.2 years) were included in a retrospective study, and with at
least 3 years’ follow-up. The endpoint events were major adverse cardiovascular
events (MACE), which included cardiac death, non-fatal myocardial infarction, and
rehospitalization with unstable angina. The primary outcomes were cardiac death and
non-fatal myocardial infarction. Patients were classiﬁed into 3 groups according to
baseline body mass index (BMI): less than 24 kg/m2 (normal weight), 24 to 28 kg/m2
(overweight), and 28 kg/m2 or more (obese).
Results: The incidence of long-term MACE was 33.6% and decreased with the levels
of BMI (the incidences of MACE were 37.9%, 34.1%, and 25.2%, respectively,
P trend¼0.031). Obese patients had a lower risk of MACE than their normal weight
counterparts (hazard ratio (HR) ¼0.58; 95% conﬁdence interval (CI), 0.37-0.91;
P¼0.016). After multivariable adjustment, the lower risk of MACE in obese patients
remained signiﬁcant (HR¼0.60; 95% CI, 0.39-0.94; P¼0.027). The overweight pa-
tients also had a lower risk of MACE than the normal weight patients in the single and
the multiple variables Cox models, but the differences were not signiﬁcant (the
P values were 0.271 and 0.272 in the single and multiple variables models, respec-
tively). Furthermore, the risks of the primary outcomes also decreased with BMI levels
in the single and multiple variables models, but all of the differences were not sta-
tistically signiﬁcant (P>0.05 for all).
Conclusions: In a population with ACS but without diabetes, obese patients had a
decreased risk of major adverse cardiovascular events compared with their normal
weight counterparts. In concordance with data in patients with diabetes, coronary
artery disease, hypertension, or heart failure, our ﬁndings further suggest a protective
effect of obesity on long-term outcomes in patients with ACS but without diabetes.
Furthermore, multi-center and large-scale prospective study are needed to evaluate the
ﬁndings.
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Growth differentiation factor 15 is an early predictor of heart failure in STEMI
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Xu Xinye, Wei Gao
Department of Cardiovascular Disease, Peking University Third Hospital
Objectives: To measure the concentration of GDF-15 in patients with STEMI and to
evaluate its potential to predict heart failure in this group of patients.
Methods: Fifty nine STEMI patients who were admitted to the hospital within 6 hours
of symptom onset were enrolled in the study. Biomarkers were measured both
immediately at the time of STEMI diagnosis and 24 hours later. Killip classiﬁcation
was evaluated 24 hours after admission.
Results: GDF-15 levels were high at the time of admission and were positively
correlated with both Killip classiﬁcation and pulmonary artery systolic pressure
(PASP). Brain natriuretic peptide (BNP) signiﬁcantly increased 24 hours after
admission and also positively correlated with Killip classiﬁcation and PASP. How-
ever, at the time of admission, there was no signiﬁcant correlation. One-way ANOVA
revealed signiﬁcant differences in GDF-15 concentrations among the different Killip
classes. Based on the receiver-operating-characteristic (ROC) curve, we determined
that a value of 716.6 pg/mL corresponded to a Killip classiﬁcation greater than Class
II; a value of 1021.1 pg/mL corresponded to a classiﬁcation higher than Class III.
Other biomarkers that were assessed in the study included TnT, IL-6, IL-8, IL-10, and
MCP-1; none of these markers correlated with either PASP or Killip class.
Conclusions: In patients with STEMI, GDF-15 is increased prior to BNP. GDF-15
may predict risk of congestive heart failure following STEMI.
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Obstructive Sleep Apnea and Gensini Score in Suspected Coronary Artery
Disease Patients
Peng Long, Jinlai Liu
the Third Afﬁliated Hospital, Sun Yat-sen UniversityC128 JACC Vol 64/16/Suppl C j October 16–1Objectives: The relationship between obstructive sleep apnea (OSA) and severity of
coronary artery disease (CAD) remains unclear. The present study aimed to determine
the association between OSA severity and Gensini score detected by 320-slice cor-
onary CTA in suspected CAD patients.
Methods: A total of 285 consecutive men (age: 60.3 9.8 years; BMI: 27.5  5.8 kg/
m2) who received polysomnography and 320-slice coronary CTA for suspected CAD
were included. Patients with prior revascularization were excluded. Suspected CAD
depended on angina-like symptoms, elevated cardiovascular risk, abnormal echocar-
diogram, positive stress ECG test and/or myocardial perfusion scintigraphies. OSA
was diagnosed according to polysomnography when the apnea-hypopnea index (AHI)
is greater than 5. Gensini scores, a method to evaluate the severity of coronary artery
disease, were gathered from 320-slice coronary CTA using the AHA 15-segment
model of coronary trees. The volunteers were divided to three groups according to
AHI: no-OSA group (AHI5), mild-OSA group (5<AHI<30) and severe-OSA group
(AHI30). Gensini scores were compared among groups using two-way ANOVA.
Spearman coefﬁcient was calculated to explore the correlation between AHI and
Gensini scores. p<0.01 was considered statistically signiﬁcant.
Results: Based on AHI, 153 patients were categorized into no-OSA group, 84 into
mild-OSA group and 48 into severe-OSA group. There were no statistical differences
among three groups in BMI, blood pressure, serum lipid level and blood glucose level.
Compared with no-OSA group, Gensini scores in mild-OSA (34.7217.47 vs
20.9613.27, p<0.01) and severe-OSA group (55.3420.57 vs 20.9613.27
p<0.01) were signiﬁcantly higher. Moreover, Gensini score in mild-OSA group was
signiﬁcantly lower than severe-OSA group (34.7217.47 vs 55.3420.57, p<0.01).
Spearman coefﬁcient indicated that the AHI of OAS positively correlated with Gensini
scores (r¼0.578, p<0.01).
Conclusions: Our study found an obvious correlation between OSA severity and
Gensini score in suspected CAD patients. OSA severity should be an assessment of
CAD risk.
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Objectives: Clinical trials produced conﬂicting results of routine intracoronary
thrombus aspiration (TA) before primary percutaneous coronary intervention (PCI) in
ST-segment elevation myocardial infarction (STEMI) patients. This study was to
perform an updated meta-analysis of randomized trials to evaluate all-cause death
events, other clinical outcomes [major adverse cardiac event (MACE), re-myocardial
infarction (Re-MI), stent thrombosis (ST), target-vessel revascularization (TVR),
target-lesion revascularization (TLR) ] and the makers of myocardial reperfusion
between TA prior to PCI (TA+PCI) compared with PCI only in STEMI patients.
Methods: The primary sources were the electronic databases of PubMed, Embase,
and the Cochrane Library from January 1990 to November 2013. Randomized clinical
trials comparing sildenaﬁl to placebo, in heart failure patients, reporting at least one
outcome of interest were included. Data were extracted regarding the characteristics
and clinical outcomes, and combined using a ﬁxed or random effect meta-analysis.
Results: A total of 25 randomized trials with 12940 patients were included. TA+PCI
A total of 25 randomized trials with 12940 patients were included. TA+PCI was
associated with signiﬁcant beneﬁts in terms of all-cause death in 6 months follow-up
(P ¼ 0.03) but not in 30 days (P ¼ 0.20). As for other clinical outcomes in 30 days
follow-up, TA+PCI was only associated with a trend of lower Re-MI rate, and in 6
months follow-up, TA+PCI had signiﬁcant lower rates of MACE, Re-MI and TLR as
compared with PCI only. Besides, TA+PCI were associated with signiﬁcantly
improved markers of myocardial reperfusion.
Conclusions: TA+PCI was associated with signiﬁcant beneﬁts in terms of all-cause
death, MACE, Re-MI and TLR in 6 months follow-up but not in 30 days follow-up,
with signiﬁcantly improved markers of myocardial reperfusion. Thus, TA is recom-
mended for routine use among STEMI patients undergoing PCI for long term
consideration.
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Objectives: The study was to access the association between resting heart rate (RHR)
and 1-year risk of major adverse cardiovascular events (MACE) in acute coronary
syndrome (ACS) patients after percutaneous coronary intervention (PCI).
Methods: A total of 808 participants with ACS after successful PCI were assigned to
the conventional treatment. MACE was deﬁned as a composite of cardiac death,
nonfatal recurrent myocardial infarction (MI), ischemic-driven revascularization, and9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
ischemic stroke. Follow-up was scheduled at 1, 3, 6, 9 and 12 months after PCI. The
association between RHR and 1-year risk of MACE was assessed using multivariate
Cox proportional hazards regression model to calculate adjusted hazard ratio (AHR)
with a 95% CI.
Results: Compared with participants with RHR >76 bpm, the AHR was 0.51 (95%
CI: 0.23 to 1.14; P¼0.100) for participants with RHR <61 bpm, and 0.44 (95%CI:
0.23 to 0.85; P¼0.014) for those with RHR between 61 bpm and 76 bpm. For par-
ticipants with RHR 61 bpm, an increase of 10 bpm in RHR was associated with an
increase by 38.0% in the risk of MACE (AHR: 1.38; 95%CI: 1.04 to 1.83; P¼0.026).
Conclusions: ACS patients after PCI with RHR >76 bpm were at higher risk of
MACE compared with those with RHR between 61 bpm and 76 bpm. Elevated RHR
61 bpm was associated with a signiﬁcantly increased risk of MACE in post-PCI
ACS patients during 1-year follow-up.
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Objectives: To evaluate the relation between left ventricular (LV) myocardial func-
tion and mitral regurgitation in patients with ischemic mitral regurgitation (IMR) by
Real-time three-dimensional dobutamine stress echocardiography (RT3D-DSE).
Methods: Ninety consecutive in-patients with myocardial infarction and IMR were
enrolled in the study, and 50 subjects of them undertook coronary artery bypass graft
surgery (CABG) in 2006-2012.Each patient underwent RT3D-DSE before treatment.
Graded Dobutamine (DOBU) was administrated intravenously with the initial dose of
5ug/kg.min, raising 3 min a time at 10-20-30-40-50ug/kg.min respectively. Positive
standard: new left ventricular wall motion abnormality detected or existing motion
abnormality got worse. Treatment stopped at dose stage of 50ug/kg.min if no positive
reactions showing. Three-dimensional (3D) heart full-volume data and 3D mitral
regurgitation were obtained at baseline and each state. Quantitative parameters
including: Left ventricular end-diastolic volume (LVEDV), Left ventricular end-
systolic volume (LVESV), left ventricular ejection fraction (LVEF), Left ventricular
diastolic mass (LVMd), Left ventricular systolic mass (LVMs).The time to the point
of minimal regional systolic volume (Tmsv) was measured from the time volume
curves of 17 segments, the standard deviation (Tmsv-SD) and maximal difference
(Tmsv-Dif) of Tmsv were calculated, and with the corresponding parameters cor-
rected by R-R interval time were evaluated together.Excursion Max (Emax),
Excursion SD (Esd), contarcta area (CA). Follow-up RT3DE was performed 1 week
after CABG. Continuous variables are expressed as means standard deviation.
One-way analyses of variance (ANOVA) were used among groups, and the LSD
method is adopted between multiple pairwise. A value of P<0.05 was considered
statistically signiﬁcant. Data were analyzed using standard statistical software (SPSS
version 17.0).
Results: At different stress state, CA decreased signiﬁcantly, and the decrement was
up to the largest at 30ug/kg.min. 2D-LVEF, 3D-LVEF increased gradually, but
decreased at 50ug/kg.min; 2D-LVESV, LVMd decreased, however increased at 50ug/
kg.min. Tmsv-16SD (%R-R) Tmsv-12SD (%R-R), Tmsv-6SD (%R-R), Tmsv-16Dif
(%R-R), Tmsv-12Dif (%R-R) and Tmsv-6Dif (%R-R) decreased, but increased at
50ug/kg.min; Eave, Esd increased, and decreased at high-dose DOBU (40-50ug/
kg.min), too ( P<0.05), Possibly because only 39 patients can tolerate high-dose
DOBU (50ug/kg.min). We compared each stress state with the baseline state, ﬁnding
that some LV remodeling parameters included 2D-LVESV, 2D-LVEDV, 2D-LVEF,
3D-LVESV, 3D–LVEDV, 3D-LVEF, 3D-SV, LVMs were statistically signiﬁcant,
and the decrement was the largest at 40ug/kg.min ( P<0.05). The CA and left ven-
tricular function were improved signiﬁcantly after CABG.
Conclusions: RT3D-DSE is useful to evaluate the heart function, and proves that the
severity of IMR decreased is associated with an improvement in LV remodeling and
synchronization.
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Objectives: Although the extent of coronary microvascular dysfunction might be
related to luminal obstruction, endothelial dysfunction, and smooth muscle cell (SMC)
dysfunction, little is known about their relation to the inﬂammatory status. The aim of
this study was to determine a possible relationship between inﬂammation, as reﬂected
by the serum C-reactive protein (CRP) levels, and index of microcirculatory resistance
(IMR) measured at the time of primary percutaneous coronary intervention in patients
with ST-segment elevation myocardial infarction (STEMI).
Methods: Thermodilution-derived IMR was measured immediately after primary
percutaneous coronary intervention in 43 patients with the use of a pressure–tem-
perature sensor wire. The mean IMR was 40.512.3. All patients were divided into 2
groups using IMR values (32 and>32). Clinical variables were compared between 2
groups based on IMR values.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CResults: Patients with higher IMR had signiﬁcantly higher serum CRP levels
(16.56.6 vs 5.94.7 p¼0.02). There were no signiﬁcant changes in the FFR values,
angiographic ﬁndings, cTnT values, and other baseline parameters between the
groups. Linear regression analysis also showed a signiﬁcant linear relationship be-
tween IMR and CRP (r ¼ 0.732, P <0.001). In multivariate analysis, the admission
CRP level was an independent predictor of increased IMR (odds ratio [OR] 1.041,
95% conﬁdence interval [CI] 1.007–1.076, p¼0.017).
Conclusions: These results have shown that the CRP levels were associated with
increased IMR in the patients with STEMI. This implies inﬂammation may contribute
to increased microvascular resistance in these patients.
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The observations of the short term efﬁcacy of routine thrombus aspiration
during primary percutaneous coronary intervention in patients with acute
ST-segment elevation myocardial infarction.
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Objectives: To evaluate the efﬁcacy of routine thrombus aspiration during primary
percutaneous coronary intervention (PPCI) in patients with ST-segment elevation
myocardial infarction (STEMI) using prospective and randomize methods.
Methods: 326 patients with STEMI underwent PPCI were divided into two groups:
115 patients were treated with routine thrombus aspiration before PPCI (thrombus
aspiration group) and 211 patients underwent PPCI without thrombus aspiration
(routine PCI group). The basic data, the incidence of no-ﬂow, corrected TIMI frame
counts (CTFC) after PCI, ST segment resolution (STR) 50% two hours after PCI,
the left ventricular ejection fraction (LVEF) within 2 weeks after PCI and the com-
binated incidence of death, recurrent myocardial infarction, heart failure and severe
arrthymias during hospitalization were eveluated.
Results: the basic data of the two group including age (62.612.1Vs 63.310.9),
male oprotion (66.8%Vs 64.2%), hypertention (54.5% Vs 55.6%), diabetes mellitus
(29.7% Vs 24.6%), percentage of smoker (53.8% Vs 47.4%), proportion of anterior
wall infarction (56.5% Vs 51.7%) are comparable (p>0.05) ; whereas in thrombus
aspiration group , the incidence of no-reﬂow is much lower (8.9% Vs 18.6%,
P< 0.05), corrected TIMI frame counts (CTFC) after PCI is fewer (21.83.3 Vs
34.6 8.1 frame, P<0.05), LVEF of 2 weeks is higher (56.2 6.0% Vs 44.5
6.2%,P<0.05), ST segment resolution (STR) 50% two hours after PCI is higher
(80.8 % Vs 66.1 %,P<0.05), the combinated incidence of death, recurrent myocardial
infarction, heart failure and severe arrthymias during hospitalization were identical
(13.3% Vs 19.9%,P>0.05).
Conclusions: Although it didn’t improve the combination of death, recurrent
myocardial infarction, heart failure and severe arrthymias, the application of thrombus
aspiration techniqe during primary PCI can reduce the incidence of no-ﬂow and
improve myocardial perfusion, thus protect cardiac function. We think routine
thrombus aspiration can serve as an important means to improve left ventricular
function, and our cunclusion need to be tested by large scale trail.
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elevation myocardial infarction patients with percutaneous coronary
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Objectives: To evaluate the impact of admission peripheral white blood cell ( WBC )
level on 30-day all-cause death and cardiovascular events in ST-segment elevation
myocardial infarction ( STEMI ) patients with percutaneous coronary interventional
( PCI ).
Methods: Analysis of 832 cases of primary PCI in STEMI patients which are divided
into six groups by admission peripheral WBC. Group A: WBC < 10 X109/L; Group B:
WBC was between 10 - 12 X109/L;Group C: WBC was between 12 -14 X109/L ,
Group D: WBC was between 14 -16 X109/L and Group E: WBC 16 X109/L. The
primary outcome was 30-day all-cause death; the secondary outcomes were rein-
farction, cardiogenic shock or deadly arrhythmia.
Results: With the peripheral WBC count increased, the primary PCI which occured
slow ﬂow or no-reﬂow incidence was increasing (P <0.05) in Group C, D, E. With the
peripheral WBC count increased,the mortality among groups showed an increasing
trend (the rate were 1.3%, 1.8%, 4.3% and 5.6% successively, P <0.05) in in Group B,
C, D, E. In Group B, C, D, 30-day combined endpoint event rate was positively
correlated with peripheral WBC count (each group were 13.0%, 27.8%, 37.5%).
Levels of WBC had a signiﬁcant positive correlation with troponin I, creatine kinase
and N-terminal pro-brain natriuretic peptide in (P <0.05), Left ventricular ejection
fraction (LVEF) was negatively correlated with peripheral WBC (P <0.05). Multi-
variate logistic regression analysis showed that the 30d mortality of Group A and
Group B had no signiﬁcant difference (P> 0.05), The risk of death 30d in the rest
groups gradually increased with the outer peripheral WBC count increased, (Group C
OR values was 1.413; Group D was 1.905; Group E was 2.619). 30-day combined
endpoint events in Group A, B, C had no signiﬁcant difference in risk, But the ofardiovascular Disease Clinical Research C129
